Join to View Full Profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-2632
Fax+1 410-328-6896
Dr. Kocoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2003 - 2006- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 1999 - 1999
Hacettepe University FOMClass of 1996
Certifications & Licensure
MD State Medical License 2014 - 2026
CT State Medical License 2010 - 2015
AR State Medical License 2006 - 2011
American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma.Djordje Atanackovic, Tim Luetkens, Dina Schneider, Peirong Hu, Xu Wang
Nature Communications. 2025-07-04 - 1 citationsObecabtagene autoleucel, a novel CD19-directed CAR T-cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia: the future for reducing toxicity and T-c...Jean A Yared, Ariel Fromowitz, Mehmet Kocoglu, Nancy Hardy, Djordje Atanackovic
Expert Review of Hematology. 2025-06-23 - 1 citationsCD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.David T Chen, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Djordje Atanackovic
Clinical Lymphoma, Myeloma & Leukemia. 2025-06-01
Abstracts/Posters
- Increased Cortical Glycolysis Following CD19 CART Therapy: A Radiographic Surrogate for an Altered Blood-Brain BarrierMehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CD19-Directed Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Large B-Cell Lymphoma: Predicti...Mehmet Hakan Kocoglu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
